1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF407 CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA ZNF8 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.23 3e-06
mRNA ADNP2 CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA GMFG CTRPv2 pan-cancer AAC 0.23 2e-06
mRNA TFAP4 CTRPv2 pan-cancer AAC 0.23 2e-09
mRNA WAS CTRPv2 pan-cancer AAC 0.24 0.0004
mRNA MBTD1 CTRPv2 pan-cancer AAC 0.24 3e-09
mRNA WRN CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.24 1e-10
Download CSV